 |
#
2011 Global Markets for External Radiation Therapy
2011 O.U.S. Markets For External Radiation Therapy
2011 U.S. Markets for External Radiation Therapy
^ Top
A
A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline:...
A Decision Support Tool for Optimizing the Melanoma Pipeline: From Res...
Abbott Laboratories Likely to Reap Benefits from Strategic Split
Acute Lymphocytic Leukemia Therapeutics Market (2010 – 2020) (Pipeline...
Acute Myelocytic Leukemia (AML) - Pipeline Review, H2 2011
Acute Myelocytic Leukemia (AML) - Pipeline Review, Q1 2011
Acute Myeloid Leukemia Therapeutics Market (2010 – 2020) (Pipeline Ass...
Adrenocortical Carcinoma Adrenal Tumor - Pipeline Review, H2 2011
Adrenocortical Carcinoma Adrenal Tumor - Pipeline Review, Q2 2011
Advancing Molecular Diagnostics to Personalize Cancer Therapy
Aging, Cancer and Age-related Disease: Common Mechanisms?
AIDS - Related Cancers - Pipeline Review, H2 2011
Aids - Related Cancers - Pipeline Review, Q2 2011
AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2012
AIDS - Related Lymphoma - Pipeline Review, H1 2012
Aids - Related Lymphoma - Pipeline Review, Q3 2011
AIDS-Related Kaposi's Sarcoma (ARKS) Therapeutics -Pipeline Assessment...
Aids-Related Kaposi's Sarcoma - Pipeline Review, Q1 2011
AIDS-Related Kaposi's Sarcoma - Pipeline Review, Q3 2011
Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Upda...
An Evaluation of Products and Technologies for Molecular Diagnostics w...
Anal Cancer - Pipeline Review, H2 2011
Anal Cancer - Pipeline Review, Q2 2011
Anal Cancer Global Clinical Trials Review, H2, 2011
Analysis of Torisel®: Adverse Events, Extravasation & Safety Signals
Analytical Tool - Angiogenesis in Oncology
Analytical Tool - Antibodies and Peptides in Oncology
Analytical Tool - Apoptosis in Oncology
Analytical Tool - Cancer Immunotherapy
Analytical Tool - Cancer Therapeutic Antibodies
Analytical Tool - Cancer Vaccines
Analytical Tool - Colorectal Cancer
Analytical Tool - Hematological Cancers
Analytical Tool - Melanoma
Analytical Tool - Pancreatic Cancer
Analytical Tool - Peptides in Oncology
Analytical Tool - Protein Kinase Inhibitors in Oncology
Anaplastic Astrocytoma - Pipeline Review, H1 2012
Anaplastic Astrocytoma - Pipeline Review, Q1 2011
Anaplastic Astrocytoma - Pipeline Review, Q3 2011
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2...
Anemia - Pipeline Review, H2 2011
Anemia Global Clinical Trials Review, Q1, 2011
Angiogenesis in Oncology Drug Pipeline Update 2011
Antibodies in Oncology Drug Pipeline Update 2011
Antibody drug conjugates for cancer treatment: Clinical Trial Pipeline...
Antibody Drug Target Atlas in Oncology
Antibody Drug Target Atlas in Oncology - Where to Commercialize in a C...
Antibody-Drug Conjugates 2011 - real breakthrough still to come. A Tec...
Anticancer Therapeutics
Antitumor Biologics - Strategies for Success in an Expanding Market
Apoptosis in Oncology Drug Pipeline Update 2011
Apoptosis: Promise Or Deception?
Apoptotic Therapeutics in Oncology - Where to Commercialize?
Approval Outlook for Avastin® as a Breast Cancer Treatment: A Survey o...
Astrocytoma - Pipeline Review, H2 2011
Astrocytoma - Pipeline Review, Q2 2011
Astrocytoma Global Clinical Trials Review, H2, 2011
Aurora Kinase inhibitors - The dawn of a new approach to cancer
Avastin (bevacizumab) - Analysis and Market Forecasts from 2016 to 202...
^ Top
B
B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 201...
B-Cell Lymphomas - Pipeline Review, H1 2012
B-Cell Lymphomas - Pipeline Review, Q1 2011
B-Cell Lymphomas - Pipeline Review, Q3 2011
Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 20...
Basal Cell Carcinoma - Pipeline Review, Q2 2011
Bile Duct Cancer Global Clinical Trials Review, H2, 2011
Bioanalysis in Cancer Research
Biologicals in Oncology Drug Pipeline Update 2011
Biologics Price Competition and Innovation (BPCI) Act - Industry Trend...
Biomarker and Diagnostic Opportunities Associated with Targeted Cancer...
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and...
Biomarkers of Kidney Disease
Biomedical Applications of Nanotechnology
Bisphosphonates and Other Bone-Targeting Compounds in the Treatment of...
Bladder Cancer - Pipeline Review, H2 2011
Bladder Cancer - Pipeline Review, Q1 2011
Bleeding and Clotting Disorders Global Clinical Trials Review, H2, 201...
Bone Cancer - Pipeline Review, H2 2011
Bone Cancer - Pipeline Review, Q2 2011
Bone Cancer Global Clinical Trials Review, H2, 2011
Bone Metastases Therapeutics - Pipeline Assessment and Market Forecast...
Bone Metastasis Global Clinical Trials Review, H2, 2011
Bone Metastasis Global Clinical Trials Review, Q2, 2011
Brain Cancer - Pipeline Review, H1 2012
Brain Cancer - Pipeline Review, Q1 2011
Brain Cancer - Pipeline Review, Q3 2011
Breast Cancer - Pipeline Review, H1 2012
Breast Cancer - Pipeline Review, Q3 2011
Breast Disease Diagnosis and Therapy Markets: Europe and Asia-Pacific
Brief Report: CD40 and CD40L (CD154) Agonists and Antagonists
Brief Report: Death Receptors TRAIL-R1/2
Brivanib - Analysis and Market Forecasts from 2013 to 2020
Building Better Cancer Vaccines: The Progress and Promise of R&D
Building on Early Successes of Immunomodulators in the Fight Against C...
Burkitt Lymphoma - Pipeline Review, H2 2011
Burkitt Lymphoma - Pipeline Review, Q2 2011
Burkitt Lymphoma Global Clinical Trials Review, H2, 2011
^ Top
C
Can Denosumab Achieve Superiority For The Prevention Of SREs In Cancer...
Can New Therapies Unseat Traditional Chemotherapy Regimens in Acute My...
Cancer Analysis
Cancer and its Management, 6th Edition
Cancer Anorexia - Pipeline Review, Q2 2011
Cancer Biologics Pipeline: Antibodies, Peptides, and Proteins - A Comp...
Cancer Biomarkers: New Tools for Transforming Cancer Management
Cancer Bundle
Cancer Cachexia: Can New Knowledge About its Biology Yield Clinical an...
Cancer Cell Therapy Markets
Cancer Chemotherapy: Basic Science to the Clinic
Cancer Diagnostic Technologies: Assessment of Emerging Technologies an...
Cancer Diagnostic Testing Instrumentation: Operating Characteristics, ...
Cancer Diagnostic Testing World Markets
Cancer Diagnostics with DNA Microarrays
Cancer Drug Blockbusters to 2016
Cancer Drug Discoveries: what the future holds FULL REPORT
Cancer Drug Discoveries: what the future holds: Colorectal Cancer Chap...
Cancer Drug Resistance
Cancer Epigenetics: Biomolecular Therapeutics in Human Cancer
Cancer Generics Market Analysis
Cancer Imaging - The Official Publication of the International Cancer ...
Cancer in Children and Young People
Cancer Pain Therapeutics - Pipeline Assessment and Market Forecasts to...
Cancer Pipeline Databook
Cancer Risk Assessment: Chemical Carcinogenesis, Hazard Evaluation, an...
Cancer Supportive Care Products Market to 2016 - Market is Expected to...
Cancer Therapeutics - Market Insight and R&D Pipeline Analysis
Cancer Therapeutics 2006: Market Dynamics and R&D Trends
Cancer Therapeutics Markets
Cancer Therapies - Global Market Opportunities
Cancer Therapies - Is the United States Always the Most Expensive Mark...
Cancer Therapies Face Increasing Reimbursement Pressures in Europe and...
Cancer Vaccines
Cancer Vaccines & Circulating Tumor Cells (CTCs) 2011 Report
Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018
Cancer Vaccines and Tumor Immunity
Cancer Vaccines Drug Pipeline Update 2011
Cancer Vaccines Fantasy or Future?
Cancer Vaccines Markets
Cancer Vaccines: From Research to Clinical Practice
Cancer Vaccines: Measuring Market Potential
Cancer: Basic Science and Clinical Aspects
Cancer: From Mechanisms to Therapeutic Approaches
Carcinoid Cancer - Pipeline Review, H2 2011
Carcinoid Cancer - Pipeline Review, Q2 2011
Carcinoma Of The Bile Duct - Pipeline Review, H2 2011
Carcinoma Of The Bile Duct - Pipeline Review, Q2 2011
Case Study: Personalized Cancer Therapy - The era of biomarker identif...
Celiac Disease - Pipeline Assessment and Market Forecasts to 2019
Cell Junctions: Adhesion, Development, and Disease
Cell Surface Markers 2011: US, Europe, Japan Forecasts by Test, Market...
Cellular Therapy in Oncology Drug Pipeline Update 2011
Cephalon To Acquire Gemin X Pharmaceuticals
Cervical Cancer - Pipeline Review, H2 2011
Cervical Cancer - Pipeline Review, Q1 2011
Cervical Cancer Therapeutics - Pipeline Assessment and Market Forecast...
Cervical Dysplasia - Pipeline Review, Q1 2011
Challenges and Opportunities in Developing Chemopreventive Agents
Challenges in Oncology Clinical Trial Design
Changes in U.S. Oncology Drug Reimbursement: Medicare Sets the Pace
Chemical Carcinogens and Anticarcinogens
Chemoprevention of Cancer and DNA Damage by Dietary Factors
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer...
Chemotherapy-Induced Neutropenia (CIN) Therapeutics -Pipeline Assessme...
China Anti-Cancer Drug Market Report 2009
Chinese Markets for Anti-Tumor Drugs
Chinese Markets for Cancer Treatment Drugs
Chinese Markets for Kidney Cancer Treatment Drugs
Chinese Markets for Liver Cancer Treatment Drugs
Chinese Markets for Skin Cancer Treatment Drugs
Chronic Idiopathic Myelofibrosis - Pipeline Review, H2 2011
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2011
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, Q1 2011
Chronic Myelocytic Leukemia (CML) - Pipeline Review, H2 2011
Chronic Myelocytic Leukemia (CML) - Pipeline Review, Q1 2011
Chronic Lymphocytic Leukemia Therapeutics Market (2010 – 2020) (Pipeli...
Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoint...
Clinical Trial Recruitment Strategies in Oncology - Online Recruitment...
Clinical Trials in Oncology
CNS Lymphoma - Pipeline Review, H1 2012
CNS Lymphoma - Pipeline Review, Q1 2011
CNS Lymphoma - Pipeline Review, Q3 2011
Colon Cancer - Pipeline Review, H1 2012
Colon Cancers - Pipeline Review, Q1 2011
Colon Cancers - Pipeline Review, Q3 2011
Colorectal Cancer - Pipeline Review, H2 2011
Colorectal Cancer - Pipeline Review, Q1 2011
Colorectal Cancer Drug Futures 2010
Colorectal Cancer Drug Pipeline Update 2011
Colorectal Cancer Global Clinical Trials Review, H2, 2011
Commercial Insight: Antihormonal Cancer Therapies - Leading brands str...
Commercial Insight: Cancer Targeted Therapies and Immunotherapies -Top...
Commercial Insight: Top 20 Cancer Therapy Brands
Commercial Insight: Top 20 Cancer Therapy Brands Forecast
Commercializing Apoptotic Drugs in Cancer: The Faster Route to Conside...
Commercializing Cancer Drugs Affecting Angiogenesis: A Decision Suppor...
Commercializing Cancer Vaccines: A Decision Support Tool for Optimizin...
Commercializing Peptides in Cancer: The Faster Route to Consider Your ...
Commercializing Peptides in Oncology: A Decision Support Tool for Opti...
Companion Diagnostics in Personalized Medicine and Cancer Therapy
Companion Diagnostics: Enabling Personalized Medicines in Cancer
Comparative Analysis of Late Stage Pipeline Molecules in Major Indicat...
Competitive Insights to Anti-Angiogenic Drug R&D in Oncology
Competitive Outlook on Antiangiogenesis and Vascular Targeting in Onco...
Competitive Outlook on Non-Antibody Based Cancer Vaccines
Competitor Analysis B7 – CD28/CTLA-4 Pathway
Competitor Analysis: c-MET/HGF Inhibitors 2011
Competitor Analysis: Cancer Vaccines
Competitor Analysis: CD3 Antagonists
Competitor Analysis: CHK and KSP/Eg5 Inhibitors
Competitor Analysis: CXCR and CXCL Agonists and Antagonists
Competitor Analysis: EGF-R Agonists and Antagonists
Competitor Analysis: G-CSF and GM-CSF
Competitor Analysis: HDAC Inhibitors 2011
Competitor Analysis: Heat shock protein 90 (Hsp90) Inhibitors
Competitor Analysis: Heat shock protein 90 (Hsp90) Inhibitors
Competitor Analysis: Her2 and Her3 Receptor Antagonists
Competitor Analysis: Hypoxia-Inducible Factor (HIF)
Competitor Analysis: IGF-1R Antagonists
Competitor Analysis: Novel Mitotic Kinase Inhibitors
Competitor Analysis: PARP Inhibitors
Competitor Analysis: PDGF-R Agonists and Antagonists
Competitor Analysis: PI3K-Akt-mTOR Pathway Inhibitors
Competitor Analysis: Plk-1 Inhibitors
Competitor Analysis: Proteasome Inhibitors
Competitor Analysis: Raf Inhibitors
Competitor Analysis: Toll-Like Receptor (TLR) Agonists & Antagonists
Competitor Analysis: VEGF and VEGF-R Agonists and Antagonists
Complete Target Atlas in Oncology Drug Development: From Tumor to Targ...
Current and Future Therapies for Colorectal Cancer - A Therapeutic & C...
Currently Druggable in Colorectal Cancer: A Drug Target Competitive An...
Currently Druggable in Melanoma: A Drug Target Competitive Analysis
Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2011
Cutaneous T-Cell Lymphoma - Pipeline Review, Q2 2011
Cytogen Corporation - SWOT Analysis
Cytogen Corporation - SWOT Framework Analysis
Cytokine Therapy in Oncology Drug Pipeline Update 2011
^ Top
D
Daily Updates: Cancer Immunotherapy - Tracking breaking research, drug...
Daily Updates: Oncology - Tracking breaking research, drug development...
Dealmaking and Industry Outlook: Targeted Cancer Therapies
Depression and Cancer
Developments in Oncolytic Viruses - An Emerging Approach to Cancer The...
Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2012
Diffuse Large B-Cell Lymphoma - Pipeline Review, Q1 2011
Diffuse Large B-Cell Lymphoma - Pipeline Review, Q3 2011
Disease and Therapy Review: Melanoma
Disease and Therapy Review: Pancreatic Cancer
DNA Repair in Cancer Therapy. Molecular Targets and Clinical Applicati...
Doxorubicin - Analysis and Market Forecasts from 2011 to 2020
Drug Delivery in Cancer - Technologies, Markets and Companies
Drug Delivery in Oncology: From Basic Research to Cancer Therapy
Drug Delivery Technology - Revolutionizing Cancer Therapies
^ Top
E
EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2011
Elan Corporation - SWOT Framework Analysis
Emerging Cancer Diagnostic Tests and Companies Developing New Technolo...
Emerging Cancer Diagnostic Tests and Companies Developing New Technolo...
Emerging Cancer Molecular Diagnostic Tests
Emerging Cancer Therapy: Microbial Approaches and Biotechnological Too...
Emerging Technologies: Stem Cells, Genes and Monoclonal Antibodies
Enabling Oncology Diagnostics: Predictive Biomarkers Based on Genes, P...
Encyclopedia of Cancer, Four-Volume Set. Edition No. 2
Endometrial Cancer - Pipeline Review, H1 2012
Endometrial Cancer - Pipeline Review, Q1 2011
Endometrial Cancer - Pipeline Review, Q3 2011
Endometrial Cancer Global Clinical Trials Review, H2, 2011
Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forec...
Ependymoma - Pipeline Review, H2 2011
Ependymoma - Pipeline Review, Q2 2011
Epidemiology: Endometrial Cancer
Epidemiology: Renal cell cancer
Erythropoietin (EPO) Stimulating Agents: Impact of Proposed CMS Guidel...
Erythropoietin (EPO) Stimulating Agents: Trends in use in Oncology - A...
Esophageal Cancer - Pipeline Review, H1 2012
Esophageal Cancer - Pipeline Review, Q1 2011
Esophageal Cancer - Pipeline Review, Q3 2011
Esophageal Cancer Global Clinical Trials Review, H2, 2011
Esophageal Cancer Therapeutics - Pipeline Assessment and Market Foreca...
European Bladder Cancer Therapeutics Markets
European Cancer IVD Market
European Cancer Support Therapies Market
European Head and Neck Cancer Therapeutics Markets
European Market for Interventional Oncology Technology
European Support Cancer Therapy
European Womens Cancer Pharmaceuticals Markets
Ewing Sarcoma - Pipeline Review, H1 2012
Ewing Sarcoma - Pipeline Review, Q1 2011
Ewing Sarcoma - Pipeline Review, Q3 2011
Ewing's Sarcoma Therapeutics - Pipeline Assessment and Market Forecast...
Eyelid Tumors, 2nd Edition
^ Top
F
Fallopian Tube Cancer - Pipeline Review, H1 2012
Fallopian Tube Cancer - Pipeline Review, Q1 2011
Fallopian Tube Cancer - Pipeline Review, Q3 2011
Fallopian Tube Cancer Global Clinical Trials Review, H2, 2011
FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for ...
FDA Reforms Fuel the Biotech Industry Growth
Follicular Lymphoma - Pipeline Review, H1 2012
Follicular Lymphoma - Pipeline Review, Q1 2011
Follicular Lymphoma - Pipeline Review, Q3 2011
Future Cancer Diagnostic Technologies and Market Applications
Future Cancer Diagnostics Market: Growth Opportunities and Business Ex...
Future Cancer Diagnostics Market: Growth Opportunities, Business Strat...
Future French Cancer Diagnostics Market: Growth Opportunities and Busi...
Future German Cancer Diagnostics Market: Growth Opportunities and Busi...
Future Italian Cancer Diagnostics Market: Growth Opportunities and Bus...
Future Japanese Cancer Diagnostics Market: Growth Opportunities and Bu...
Future Oncology
Future Spanish Cancer Diagnostics Market: Growth Opportunities and Bus...
Future Technology Trends and Upcoming Players in Hemophilia Therapeuti...
Future UK Cancer Diagnostics Market: Growth Opportunities and Business...
Future US Blood Banking Market: Growth Opportunities and Business Expa...
Future US Cancer Diagnostics Market: Growth Opportunities and Business...
^ Top
G
Gallbladder Cancer - Pipeline Review, H2 2011
Gallbladder Cancer - Pipeline Review, Q2 2011
Gallbladder Cancer Global Clinical Trials Review, H2, 2011
Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 ...
Gastric Cancer - Pipeline Review, H2 2011
Gastric Cancer - Pipeline Review, Q1 2011
Gastric Cancer Global Clinical Trials Review, H2, 2011
Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2012
Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H...
Gastrointestinal Stromal Tumors (GIST) - Pipeline Review, Q1 2011
Gastrointestinal Stromal Tumors (GIST) - Pipeline Review, Q3 2011
Gastrointestinal Stromal Tumors (GIST) Therapeutics - Pipeline Assessm...
Gene Therapy in Oncology Drug Pipeline Update 2011
Germ Cell Tumors - Pipeline Review, H2 2011
Germ Cell Tumors - Pipeline Review, Q2 2011
Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2012
Glioblastoma Multiforme (GBM) - Pipeline Review, Q3 2011
Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2011
Glioblastoma Multiforme (GBM) Therapeutics - Pipeline Assessment and M...
Glioblastoma Multiforme - Pipeline Review, Q1 2011
Glioma - Pipeline Review, H1 2012
Glioma - Pipeline Review, Q1 2011
Glioma - Pipeline Review, Q3 2011
Glioma Global Clinical Trials Review, H2, 2011
Global Cancer Biomarkers Market (2010 - 2015)
Global Cancer Drugs market 2009-2013
Global Cancer Focus Company Directory
Global Cancer Treatment Forecast to 2012
Global Colorectal Cancer Drug Pipeline Capsule - 2012
Global Gastric Cancer Drug Pipeline Capsule - 2011
Global Gastric Cancer Drug Pipeline Capsule - 2012
Global Head and Neck Cancer Drug Pipeline Capsule - 2012
Global Liver Cancer Drug Pipeline Capsule - 2012
Global Lung Cancer Surgery Market (Devices & Treatment Outlook) – Tren...
Global miRNA Market Outlook
Global Neurosurgical Product Markets
Global Oncology Drug Market: Strategic Assessments of Leading Supplier...
Global Pipeline Review & Analysis of Hematological Malignancies
Global Prostate Cancer Therapeutics Market (2010 – 2020) (Opportunity ...
Global Radiation Oncology Market 2009-2013
Global Radiation Therapy Market Report: 2011 Edition
Global Radiation Therapy Market: 2010 Edition
Global Renal Cancer Drug Pipeline Capsule - 2012
Global Stem Cell and Advanced Technologies Market
Graft Versus Host Disease (GVHD) Therapeutics - Pipeline Assessment an...
GV1001 (Pancreatic Cancer) - Analysis and Forecasts to 2020
Gynecologic Oncology: Evidence-Based Perioperative and Supportive Care...
Gynecological Cancer Management: Identification, Diagnosis and Treatme...
^ Top
H
Head And Neck Cancer - Pipeline Review, H2 2011
Head And Neck Cancer - Pipeline Review, Q1 2011
Head and Neck Cancer Drug Pipeline Update 2011
Head and Neck Cancer Global Clinical Trials Review, H2, 2011
Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2011
Helical/Arc-Based Radiation Oncology Equipment Assessment
Hematological Cancers - A Therapeutic & Competitive Insight
Hematological Cancers Drug Pipeline Update 2011
Hematology
Hematology and Medical Oncology Best Practices
Hemoglobinuria Global Clinical Trials Review, H2, 2011
Hemoglobinuria Global Clinical Trials Review, Q1, 2011
Hemophilia - Pipeline Review, H2 2011
Hemophilia A - Pipeline Review, H2 2011
Hemophilia A Global Clinical Trials Review, Q1, 2011
Hemophilia B - Pipeline Review, H2 2011
Hemophilia B Global Clinical Trials Review, H2, 2011
Hemophilia B Global Clinical Trials Review, Q1, 2011
Hemophilia Global Clinical Trials Review, H2, 2011
Hemophilia Global Clinical Trials Review, Q1, 2011
Hemorrhage Global Clinical Trials Review, H2 2011
Hemorrhage Global Clinical Trials Review, Q2, 2011
Hemostasis Global Clinical Trials Review, Q1, 2011
Hepatic Tumor Global Clinical Trials Review, H2, 2011
Hepatocellular Carcinoma - Pipeline Review, H1 2012
Hepatocellular Carcinoma - Pipeline Review, Q1 2011
Hepatocellular Carcinoma - Pipeline Review, Q3 2011
Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2012
HIV-Related Lymphoma - Pipeline Review, Q1 2011
Hodgkin Lymphoma - Pipeline Review, H1 2012
Hodgkin Lymphoma - Pipeline Review, Q1 2011
Hodgkin Lymphoma - Pipeline Review, Q3 2011
Hodgkin Lymphoma Global Clinical Trials Review, H2, 2011
Hormone Refractory Prostate Cancer - Pipeline Review, H2 2011
Hormone Refractory Prostate Cancer - Pipeline Review, Q2 2011
Hypoalbuminemia Global Clinical Trials Review, Q2, 2011
Hypopharyngeal Cancer - Pipeline Review, H2 2011
Hypopharyngeal Cancer - Pipeline Review, Q2 2011
Hypopharyngeal Cancer Global Clinical Trials Review, Q1, 2011
^ Top
I
ID Signaling Pathway in Oncology Drug Pipeline Update 2011
IL-1 Signaling Pathway in Oncology Drug Pipeline Update 2011
IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2011
IL-3 Signaling Pathway in Oncology Drug Pipeline Update 2011
IL-4 Signaling Pathway in Oncology Drug Pipeline Update 2011
IL-5 Signaling Pathway in Oncology Drug Pipeline Update 2011
IL-6 Signaling Pathway in Oncology Drug Pipeline Update 2011
IL-7 Signaling Pathway in Oncology Drug Pipeline Update 2011
IL-9 Signaling Pathway in Oncology Drug Pipeline Update 2011
Immune Thombocytopenic Purpura (ITP) Global Clinical Trials Review, Q2...
Immunotherapy in Oncology Drug Pipeline Update 2011
Immunotherapy in Oncology: Gaining Momentum
Individualizing and Monitoring Cancer Therapy
Indolent Lymphoma - Pipeline Review, H2 2011
Indolent Lymphoma - Pipeline Review, Q2 2011
Industry Analysis - How Companies Can Maintain the Market Success of C...
Information-Seeking Patterns of U.S. Oncologists
Innovations in Cancer: Novel Therapeutics, New Diagnostics and Future ...
Innovations in Oncology Diagnostics: Technological Advances, Growth Op...
Innovations in Protein Kinase Therapies - Significant Proportion of Pr...
Innovative and Targeted Cancer Therapies: Key Technologies, New Applic...
Interventional Techniques in Uro-Oncology
Irritable Bowel Syndrome Epidemiology by Sub-Type in G7 Countries
Islet Cell Carcinoma (Insulinoma) - Pipeline Review, H2 2011
Islet cell carcinoma (Neuroendocrine Tumors) - Pipeline Review, Q2 201...
Issues; Trends and Prevalence in the European Cancer Therapy Market- N...
^ Top
J
Jakafi (ruxolitinib) Gains US FDA Approval to Become the First Drug Ev...
Journal of Chemotherapy
^ Top
K
Key Trends in European Patient Monitoring Systems Market
Key Trends in the Political and Reimbursement Environment for Cancer D...
Kidney Cancer - Pipeline Review, H1 2012
Kidney Cancer - Pipeline Review, Q1 2011
Kidney Cancer - Pipeline Review, Q3 2011
Kidney Cancer Global Clinical Trials Review, H2, 2011
Kit Receptor Signaling Pathway in Oncology Drug Pipeline Update 2011
^ Top
L
Large Pharma: 2004 A Year Of Progress
Laryngeal Cancer - Pipeline Review, H2 2011
Laryngeal Cancer - Pipeline Review, Q2 2011
Laryngeal Cancer Global Clinical Trials Review, H2, 2011
Latin American Oncology Therapeutics Markets
Leading Cancer Diagnostics Market Players: Strategic Assessments of Ma...
Lecture Notes: Oncology, 2nd Edition
Leukemia Global Clinical Trials Review, H2, 2011
Leukemia Therapeutics Market (2010-2020) (Acute/Chronic lymphocytic le...
Leukemias - Pipeline Review, H1 2012
Leukemias - Pipeline Review, Q1 2011
Leukemias - Pipeline Review, Q3 2011
Licensing Opportunities: Cancer Vaccines
Linifanib - Assessment and Market Forecasts from 2013 to 2020
Lip And Oral Cavity Cancer - Pipeline Review, H2 2011
Lip And Oral Cavity Cancer - Pipeline Review, Q2 2011
Lip and Oral Cavity Cancer Global Clinical Trials Review, Q2, 2011
Lip and Oral Cavity Cancer Therapeutics - Pipeline Assessment and Mark...
Lipid Nanocarriers in Cancer Diagnosis and Therapy
Liver Cancer - Pipeline Review, H1 2012
Liver Cancer - Pipeline Review, Q1 2011
Liver Cancer - Pipeline Review, Q3 2011
Liver Cancer Drug Pipeline Update 2011
Liver Cancer Drugs - Global Strategic Business Report
Liver Cancer Global Clinical Trials Review, H2, 2011
Looking at the Cancer Therapy Market
Lung Cancer - Pipeline Review, H1 2012
Lung Cancer - Pipeline Review, Q1 2011
Lung Cancer - Pipeline Review, Q3 2011
Lung Cancer Drug Pipeline Update 2011
Lung Cancer Global Clinical Trials Review, H2, 2011
Lung Cancer Therapeutics Market (NSCLC & SCLC) - 2010-2020 (Pipeline A...
Lung Cancer Therapeutics Market Outlook and Pipeline Analysis
Lymphedema Global Clinical Trials Review, Q1, 2011
Lymphoma - Pipeline Review, H1 2012
Lymphoma - Pipeline Review, Q1 2011
Lymphoma - Pipeline Review, Q3 2011
^ Top
M
Malignant Liver Tumors: Current and Emerging Therapies, 3rd Edition
Malignant Mesothelioma - Pipeline Review, H1 2012
Malignant Mesothelioma - Pipeline Review, Q1 2011
Malignant Mesothelioma - Pipeline Review, Q3 2011
Malignant Mesothelioma Therapeutics - Pipeline Assessment and Market F...
Mantle Cell Lymphoma - Pipeline Review, H1 2012
Mantle Cell Lymphoma - Pipeline Review, Q1 2011
Mantle Cell Lymphoma - Pipeline Review, Q3 2011
Manual of Pediatric Hematology and Oncology. Edition No. 5
Market and Product Forecasts: Targeted Cancer Therapies - Trend toward...
Market and Product Forecasts: Top 20 Oncology Therapy Brands - The val...
Market Potential of ACAPODENE® FOR ADT-Associated Osteoporosis: A Pane...
MarketWatch: Cancer
MDV3100 Raises Hopes for Medivation
Medullary Thyroid Cancer - Pipeline Review, H1 2012
Medullary Thyroid Cancer - Pipeline Review, Q1 2011
Medullary Thyroid Cancer - Pipeline Review, Q3 2011
Medullary Thyroid Cancer Global Clinical Trials Review, Q1, 2011
Medulloblastoma - Pipeline Review, H1 2012
Medulloblastoma - Pipeline Review, Q1 2011
Medulloblastoma - Pipeline Review, Q3 2011
Melanoma - Pipeline Review, H2 2011
Melanoma - Pipeline Review, Q1 2011
Melanoma Drug Pipeline Update 2011
Melanoma Global Clinical Trials Review, H2 2011
Melanoma Therapeutics - Global Strategic Business Report
Metastatic Brain Tumors - Pipeline Review, H2 2011
Metastatic Brain Tumors - Pipeline Review, Q2 2011
Metastatic Breast Cancer - Pipeline Review, H1 2012
Metastatic Breast Cancer - Pipeline Review, Q1 2011
Metastatic Breast Cancer - Pipeline Review, Q3 2011
Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2011
Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, Q2 2011
Metastatic Liver Cancer - Pipeline Review, H1 2012
Metastatic Liver Cancer - Pipeline Review, Q1 2011
Metastatic Liver Cancer - Pipeline Review, Q3 2011
Metastatic Lung Cancer - Pipeline Review, H2 2011
Metastatic Lung Cancer - Pipeline Review, Q2 2011
Metastatic Melanoma - Pipeline Review, H1 2012
Metastatic Melanoma - Pipeline Review, Q1 2011
Metastatic Melanoma - Pipeline Review, Q3 2011
Metastatic Melanoma: Pipeline Assessment and Market Potential Through ...
Metastatic Pancreatic Cancer - Pipeline Review, H1 2012
Metastatic Pancreatic Cancer - Pipeline Review, Q1 2011
Metastatic Pancreatic Cancer - Pipeline Review, Q3 2011
MicroRNA Diagnostics, Therapeutics, and Cancer Personalized Medicine 2...
MicroRNA Profiling in Cancer: A Bioinformatics Perspective
Miripla - Analysis and Market Forecasts from 2010 to 2020
Molecular Cancer Therapeutics: Strategies for Drug Discovery and Devel...
Molecular Diagnostics in Cancer Testing
Molecular Diagnostics: The Key Driver in Personalized Cancer Medicine
Molecular Pathology of Pituitary Adenomas
Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer
Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2012
Multiple Myeloma - Pipeline Review, Q1 2011
Multiple Myeloma - Pipeline Review, Q3 2011
Multiple Myeloma Global Clinical Trials Review, H2, 2011
Muparfostat - Analysis and Market Forecasts from 2017 to 2020
Myelodysplastic Syndrome - Pipeline Review, Q1 2011
Myelodysplastic Syndrome Therapeutics - Pipeline Assessment and Market...
Myelofibrosis - Pipeline Review, H2 2011
Myeloproliferative Disorders Global Clinical Trials Review, Q2, 2011
^ Top
N
NANO Magazine - Issue 11
NANO Magazine - Issue 12
NANO Magazine - Issue 5
Nasopharyngeal Cancer - Pipeline Review, H1 2012
Nasopharyngeal Cancer - Pipeline Review, Q1 2011
Nasopharyngeal Cancer - Pipeline Review, Q3 2011
Natural Killer Cell Lymphomas - Pipeline Review, H1 2012
Natural Killer Cell Lymphomas - Pipeline Review, Q1 2011
Natural Killer Cell Lymphomas - Pipeline Review, Q3 2011
Neuro Endocrine Carcinoma - Pipeline Review, Q2 2011
Neuroblastoma - Pipeline Review, H1 2012
Neuroblastoma - Pipeline Review, Q1 2011
Neuroblastoma - Pipeline Review, Q3 2011
Neuroendocrine Carcinoma Global Clinical Trials Review, Q1, 2011
Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market...
Neuroendocrine Tumors Drug Pipeline Update 2011
Neurofibromatosis - Pipeline Review, Q2 2011
Neurological Complications in Cancer Patients (Complicanze Neurologich...
Neutropenia - Pipeline Review, H2 2011
New Approaches to the Treatment of Non-Hodgkin's Lymphoma
New Concepts in Cancer Therapeutics
Nexavar - Analysis and Market Forecasts from 2007 to 2020
Non-Hodgkin Lymphoma - Pipeline Review, H2 2011
Non-Hodgkin Lymphoma - Pipeline Review, Q1 2011
Non-Hodgkin Lymphoma Global Clinical Trials Review, H2, 2011
Non-Small Cell Lung Cancer (NSCLC) Therapeutics - Pipeline Assessment ...
Non-Small Cell Lung Cancer - Pipeline Review, H2 2011
Non-Small Cell Lung Cancer - Pipeline Review, Q1 2011
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2012
Nonhematologic Malignancy Global Clinical Trials Review, Q1, 2011
Nonmelanomatous Skin Cancer - Pipeline Review, H2 2011
Nonmelanomatous Skin Cancer - Pipeline Review, Q2 2011
Notch Signaling Pathway in Oncology Drug Pipeline Update 2011
Novartis's Zelnorm Suspension - Impact On The Irritable Bowel Syndrome...
Novel Strategies in Oncology Clinical Trials: The Use of Biological an...
Nuclear Oncology
Nucleic Acid Therapies in Oncology Drug Pipeline Update 2011
^ Top
O
Oligodendroglioma - Pipeline Review, H2 2011
Oligodendroglioma - Pipeline Review, Q2 2011
Oncology Market Access in India - The commercial potential is high, bu...
Oncology Market Forecast to 2015: Brand Spending and Development Oppor...
Oncology Market in China to 2017 - Better Access to Cancer Therapies f...
Oncology Market Opportunities, Strategies, and Forecasts, 2006 To 2012...
Oncology Media Monitor
Oncology Partnering Agreements in Pharma, Biotech and Diagnostics
Oncology Pharmaceuticals Market in India 2011
Oncology Pipeline Database
Oncology Pipelines: Is the Future Targeted Therapy?
Oncology Review and Outlook 2010
Oncology Therapeutics Market to 2017 - High Unmet Need in the Manageme...
Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence...
Opportunities and Challenges in the Japanese Market for Cancer Therapi...
Optimizing Treatment for Bone Metastases in Advanced Cancers 2011
Optimizing Treatment for Metastatic Clear Cell Renal Cell Carcinoma: U...
Oral Cancer Global Clinical Trials Review, H2, 2011
Oral Mucositis Therapeutics - Pipeline Assessment and Market Forecasts...
Oropharyngeal Cancer - Pipeline Review, H2 2011
Oropharyngeal Cancer - Pipeline Review, Q2 2011
Oropharyngeal Cancer Therapeutics - Pipeline Assessment and Market For...
Osteosarcoma - Pipeline Review, H2 2011
Osteosarcoma - Pipeline Review, Q2 2011
Osteosarcoma Global Clinical Trials Review, H2, 2011
Osteosarcoma Therapeutics - Pipeline Assessment and Market Forecasts t...
Outlook for Cancer Vaccine Development
Ovarian Cancer - Pipeline Review, H1 2012
Ovarian Cancer - Pipeline Review, Q1 2011
Ovarian Cancer - Pipeline Review, Q3 2011
Ovarian Cancer Global Clinical Trials Review, H2, 2011
Overview of Indian Oncology Market
^ Top
P
Pancreatic Cancer - Pipeline Review, H2 2011
Pancreatic Cancer - Pipeline Review, Q2 2011
Pancreatic Cancer Drug Pipeline Update 2011
Pancreatic Cancer Drugs - Global Strategic Business Report
Pancreatic Cancer Global Clinical Trials Review, H2, 2011
Pancytopenia Global Clinical Trials Review, Q1, 2011
Pediatric Cancer - Pipeline Review, H2 2011
Pediatric Cancer - Pipeline Review, Q2 2011
Pediatric Hematology and Oncology: Scientific Principles and Clinical ...
Penile Cancer - Pipeline Review, H1 2012
Penile Cancer - Pipeline Review, Q1 2011
Penile Cancer - Pipeline Review, Q3 2011
Peptides in Oncology Drug Pipeline Update 2011
Peritoneal Cancer - Pipeline Review, H1 2012
Peritoneal Cancer - Pipeline Review, Q1 2011
Peritoneal Cancer Global Clinical Trials Review, H2, 2011
Peritoneal Tumor - Pipeline Review, Q3 2011
Peritoneal Tumor Global Clinical Trials Review, H2, 2011
Peritoneal Tumor Global Clinical Trials Review, Q2, 2011
Personalized Medicine for Cancer
PET/CT and SPECT/CT To Plan and Monitor the Treatment of Cancer
Pharyngeal Neoplasms Global Clinical Trials Review, Q1, 2011
Phenotypic and Genotypic Diagnosis of Malignancies: An Immunohistochem...
Pheochromocytoma - Pipeline Review, H2 2011
Pheochromocytoma - Pipeline Review, Q2 2011
Pipeline Insight: Cancer Overview - Lung, Brain, Head and Neck, Thyroi...
Pipeline Insight: Cancer Overview Malignant Melanoma, Neuroendocrine T...
Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - ...
Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic gastro...
Pipeline Insight: Lymphomas, Multiple Myeloma & Myelodysplastic Syndro...
Pipeline Insight: Small Molecule Targeted Cancer Therapies - New targe...
Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of First Appr...
Pituitary Neoplasms Global Clinical Trials Review, Q1, 2011
Plasma Cell Neoplasm - Pipeline Review, H2 2011
Plasma Cell Neoplasm - Pipeline Review, Q2 2011
Polycythemia Vera - Pipeline Review, H2 2011
Portfolio Analytics in the Pancreatic Cancer Pipeline and Portfolio Pl...
Positioning And Market Potential Of Cms-024 (Ysl, Tyroserleutide) In H...
PrevOnco - Analysis and Market Forecasts from 2014 to 2020
Pricing and Reimbursement of Targeted Cancer Therapies
Primitive Neuroectodermal Tumor (PNET) - Pipeline Review, H2 2011
Primitive Neuroectodermal Tumor - Pipeline Review, Q2 2011
Problem Solving in Oncology
Product Profiles: Targeted Cancer Therapies - Trend towards personaliz...
Prostate and Breast Cancer- New Treatments & Developmental Progress
Prostate Cancer - Pipeline Review, H2 2011
Prostate Cancer - Pipeline Review, Q1 2011
Prostate Cancer Global Clinical Trials Review, H2, 2011
Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2011
Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Proteins in Oncology Drug Pipeline Update 2011
Provenge fails to Live up to Dendreon's Expectations
^ Top
R
R&D Trends: Prostate Cancer - Newly approved therapies shift treatment...
R&D Update: How Can Companies Improve on Existing Antiangiogenesis Age...
Radiation Oncology Equipment Assessment: A Survey of Twenty-Seven US-b...
Radiation Therapy in Oncology Drug Pipeline Update 2011
Radiology, Nuclear Medicine, Radiation Therapy, 2nd Edition
Ramucirumab - Analysis and Market Forecasts from 2014 to 2020
Recent Advances in Clinical Oncology
Rectal Cancer - Pipeline Review, H1 2012
Rectal Cancer - Pipeline Review, Q1 2011
Rectal Cancer - Pipeline Review, Q3 2011
Rectal Cancer Global Clinical Trials Review, H2, 2011
Renal Anemia - Pipeline Review, H2 2011
Renal Cancer Drug Pipeline Update 2011
Renal Cell Carcinoma - Pipeline Review, H1 2012
Renal Cell Carcinoma - Pipeline Review, Q1 2011
Renal Cell Carcinoma - Pipeline Review, Q3 2011
Renal Cell Carcinoma Cancer Drug Futures 2010
Retinoblastoma - Pipeline Review, H2 2011
Retinoblastoma Global Clinical Trials Review, Q1, 2011
Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesi...
RNA Interference Therapy in Oncology Drug Pipeline Update 2011
Roadmap for Success in Oncology
^ Top
S
Salient Review Colorectal Cancer: Advances in Blood Biomarkers, 2011
Salivary Gland Cancer - Pipeline Review, H2 2011
Salivary Gland Cancer - Pipeline Review, Q2 2011
Salivary Gland Cancer Global Clinical Trials Review, Q1, 2011
Sarcomas - Pipeline Review, H1 2012
Sarcomas - Pipeline Review, Q1 2011
Sarcomas - Pipeline Review, Q3 2011
Sarcomas and their Subtypes
Sezary Syndrome - Pipeline Review, H2 2011
Sezary Syndrome - Pipeline Review, Q2 2011
Sickle Cell Anemia Therapeutics - Pipeline Assessment and Market Forec...
Sickle Cell Disease Global Clinical Trials Review, H2, 2011
Sickle Cell Disease Global Clinical Trials Review, Q1, 2011
Skin Cancer
Skin Neoplasms Global Clinical Trials Review, Q1, 2011
Small Intestine Cancer - Pipeline Review, H1 2012
Small Intestine Cancer - Pipeline Review, Q1 2011
Small Intestine Cancer - Pipeline Review, Q3 2011
Small-Cell Lung Cancer - Pipeline Review, H1 2012
Small-Cell Lung Cancer - Pipeline Review, Q1 2011
Small-Cell Lung Cancer - Pipeline Review, Q3 2011
Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2012
Soft Tissue Sarcoma - Pipeline Review, H2 2011
Soft Tissue Sarcoma - Pipeline Review, Q2 2011
Soft Tissue Tumors: A Multidisciplinary, Decisional Diagnostic Approac...
Solid Tumor - Pipeline Review, H1 2012
Solid Tumor Global Clinical Trials Review, H1, 2012
Solid Tumors - Pipeline Review, Q1 2011
Solid Tumors - Pipeline Review, Q3 2011
Squamous Cell Carcinoma - Pipeline Review, H2 2011
Squamous Cell Carcinoma - Pipeline Review, Q2 2011
Stakeholder Insight: Cancer Pain - Physician survey highlights inadequ...
Stakeholder Insight: Gastric Cancer
Stakeholder Opinions: Cancer Cachexia - Higher Profile Needed to Unloc...
Stakeholder Opinions: Cervical and Endometrial Cancer - Opportunities ...
Stakeholder Opinions: Hepatocellular cancer
Stakeholder Opinions: Pancreatic Cancer - Gemzar Dominance will Contin...
Stomatitis Global Clinical Trials Review, Q1, 2011
Strategic Analysis of the European In Vitro Cancer Diagnostics Market
Strategic Assessment of Oncology Research and Opportunities in the Asi...
Strategic Outlook On Protein Kinase Inhibitors in Oncology
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for t...
^ Top
T
T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 201...
T-Cell Leukemia - Pipeline Review, H1 2012
T-Cell Leukemia - Pipeline Review, Q1 2011
T-Cell Leukemia - Pipeline Review, Q3 2011
T-Cell Lymphomas - Pipeline Review, H2 2011
T-Cell Lymphomas - Pipeline Review, Q2 2011
Talactoferrin Alfa (NSCLC) - Analysis and Forecasts to 2020
Tarceva - Analysis and Market Forecasts from 2013 to 2020
Target Atlas in Oncology Drug Development: Major Tumor Types
Target Atlas in Oncology Drug Development: Targeted Therapies
Target-Based Approaches for Discovering Novel Oncology Drugs
Targeted Cancer Therapies: Innovative Drugs And Their Impact On The Fu...
Targeted Cancer Therapies: Novel Targets, Technologies, and Dealmaking...
Targeting Cancer Stem Cells: Therapeutic Strategies and Pipeline Devel...
Targeting Protein Kinases for Cancer Therapy
Testicular Cancer - Pipeline Review, H2 2011
Testicular Cancer - Pipeline Review, Q2 2011
Testicular Cancer Global Clinical Trials Review, H2, 2011
Testicular Cancer Therapeutics - Pipeline Assessment and Market Foreca...
TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2...
Thalassemia Global Clinical Trials Review, Q1, 2011
Thalidomide - Analysis and Market Forecasts from 2015 to 2020
The 2011 AFP Testing Market: US, Europe, Japan: Test Volume, Sales For...
The 2011 ASCO (American Society of Clinical Oncology) Annual Meeting -...
The 2011 Cancer Diagnostics Market: New Product Development Opportunit...
The 2011 Cancer Diagnostics Market: US, Europe, Japan - Emerging Oppor...
The 2011 French Cancer Diagnostics Market
The 2011 German Cancer Diagnostics Market
The 2011 Global Cancer Diagnostic Market Overview - Facilities, Test V...
The 2011 Italian Cancer Diagnostics Market
The 2011 Japanese Cancer Diagnostics Market
The 2011 Spanish Cancer Diagnostics Market
The 2011 UK Cancer Diagnostics Market
The 2011 US Cancer Diagnostics Market
The Biology and Treatment of Cancer: Understanding Cancer
The Biology of Cancer, 2nd Edition
The Cancer Clock
The Cancer Market Outlook to 2010
The Cancer Market Outlook to 2016
The Commercial Success of Cancer Therapeutic Antibodies - The Formatio...
The Complete Guide to Targeted Therapies in Oncology: A World Review
The Drug Target Atlas of Protein Kinase Inhibitors in Oncology
The Future of Oncology Therapeutics - Market Forecasts to 2015, Compet...
The Global Competitive Landscape of Antibody Drug Development in Cance...
The Proton-Deuterium Swap - Will the Heavy Strategy Work?
The Targeted Cancer Therapies Pipeline: A Strategic Review
The Top 50 Oncology Contract Research Organisations In Europe
The War On Cancer - 2nd Edition
The World Cancer Market Yearbook 2005
Therapeutic Peptides in Oncology - Favorable Conditions But Where to C...
Therapeutic Peptides in Oncology: Drug Pipeline Update 2009
Therapeutics Targeting ERB Family
ThermoDox - Analysis and Market Forecasts from 2012 to 2020
Thought Leader Insight & Analysis Report - Pancreatic Cancer Q3 2010
Throat Cancer - Pipeline Review, H2 2011
Throat Cancer - Pipeline Review, Q2 2011
Thrombocytopenia - Pipeline Review, H2 2011
Thrombocytopenia Global Clinical Trials Review, Q1, 2011
Thrombophilia Global Clinical Trials Review, Q2, 2011
Thrombotic Thrombocytopenic Purpura - Pipeline Review, H2 2011
Thymus Cancer - Pipeline Review, H2 2011
Thymus Cancer - Pipeline Review, Q2 2011
Thymus Cancer Global Clinical Trials Review, H2, 2011
Thyroid Cancer - Pipeline Review, H2 2011
Thyroid Cancer - Pipeline Review, Q2 2011
Thyroid Cancer Global Clinical Trials Review, H2, 2011
Thyroid Cancer Therapeutics - Pipeline Assessment and Market Forecast ...
TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2011
TNM Classification of Malignant Tumours, 7th Edition
Top 20 Cancer Therapy Brands in Australia Forecast
Top 20 Manufacturers Of Point-Of-Care Diagnostics For Oncology
Top 7 Cancer Indications - Therapeutic & Competitive Insights
Towards Personalized Medicine for Cancer
Transitional Cell Cancer - Pipeline Review, H2 2011
Transitional Cell Cancer - Pipeline Review, Q2 2011
Trends in the Commercialization of Biomarkers: Tests and Companies
Triple Analysis: Angiogenesis, Antibodies and Peptides
Triple Analysis: Angiogenesis, Cancer Vaccines and Antibodies
Triple Analysis: Angiogenesis, Cancer Vaccines and Peptides
Triple Analysis: Angiogenesis, Cancer Vaccines and Protein Kinase Inhi...
|
|